folate binding protein J65 peptide vaccine
Term · Oncology and biomedicine · MLC-T-ONC-013740
A cancer vaccine comprised of human leukocyte antigen (HLA)-A2-restricted folate binding protein (FBP) epitope J65 (9 amino acids; EIWTFSTKV), with potential immunostimulatory and antineoplastic activities. Upon intradermal injection, FBP J65 peptide vaccine may induce a specific cytotoxic T-lymphocyte (CTL) response against J65 FBP-expressing tumor cell types. FBP is a membrane-bound, tumor-associated antigen overexpressed in various tumor types, including breast, ovarian and endometrial cancers. J65 is a strongly immunogenic peptide.
| Identifier | MLC-T-ONC-013740 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | FBP J65 peptide vaccine; J65 peptide vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013740",
"term": "folate binding protein J65 peptide vaccine",
"field": "Oncology and biomedicine",
"definition": "A cancer vaccine comprised of human leukocyte antigen (HLA)-A2-restricted folate binding protein (FBP) epitope J65 (9 amino acids; EIWTFSTKV), with potential immunostimulatory and antineoplastic activities. Upon intradermal injection, FBP J65 peptide vaccine may induce a specific cytotoxic T-lymphocyte (CTL) response against J65 FBP-expressing tumor cell types. FBP is a membrane-bound, tumor-associated antigen overexpressed in various tumor types, including breast, ovarian and endometrial cancers. J65 is a strongly immunogenic peptide.",
"synonyms": [
"FBP J65 peptide vaccine",
"J65 peptide vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/folate-binding-protein-j65-peptide-vaccine/"
}
Record 7,514 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.